Surgery Partners Operating Margin 2013-2024 | SGRY
Current and historical operating margin for Surgery Partners (SGRY) over the last 10 years. The current operating profit margin for Surgery Partners as of June 30, 2024 is 3.13%.
| Surgery Partners Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2024-06-30 | $2.89B | $0.35B | 11.95% |
| 2024-03-31 | $2.79B | $0.36B | 12.81% |
| 2023-12-31 | $2.74B | $0.33B | 11.96% |
| 2023-09-30 | $2.72B | $0.32B | 11.82% |
| 2023-06-30 | $2.66B | $0.31B | 11.72% |
| 2023-03-31 | $2.61B | $0.29B | 11.15% |
| 2022-12-31 | $2.54B | $0.35B | 13.59% |
| 2022-09-30 | $2.44B | $0.37B | 14.99% |
| 2022-06-30 | $2.38B | $0.36B | 14.96% |
| 2022-03-31 | $2.31B | $0.34B | 14.69% |
| 2021-12-31 | $2.22B | $0.30B | 13.62% |
| 2021-09-30 | $2.16B | $0.28B | 13.14% |
| 2021-06-30 | $2.10B | $0.24B | 11.39% |
| 2021-03-31 | $1.93B | $0.22B | 11.60% |
| 2020-12-31 | $1.86B | $0.18B | 9.89% |
| 2020-09-30 | $1.83B | $0.16B | 8.75% |
| 2020-06-30 | $1.79B | $0.20B | 11.20% |
| 2020-03-31 | $1.86B | $0.21B | 11.37% |
| 2019-12-31 | $1.83B | $0.24B | 12.94% |
| 2019-09-30 | $1.81B | $0.11B | 6.26% |
| 2019-06-30 | $1.79B | $0.10B | 5.55% |
| 2019-03-31 | $1.78B | $0.09B | 4.90% |
| 2018-12-31 | $1.77B | $0.08B | 4.40% |
| 2018-09-30 | $1.74B | $0.21B | 12.07% |
| 2018-06-30 | $1.61B | $0.16B | 10.10% |
| 2018-03-31 | $1.47B | $0.16B | 10.72% |
| 2017-12-31 | $1.34B | $0.16B | 11.79% |
| 2017-09-30 | $1.19B | $0.15B | 12.31% |
| 2017-06-30 | $1.16B | $0.19B | 16.42% |
| 2017-03-31 | $1.17B | $0.20B | 17.51% |
| 2016-12-31 | $1.15B | $0.20B | 17.10% |
| 2016-09-30 | $1.10B | $0.15B | 13.51% |
| 2016-06-30 | $1.06B | $0.15B | 14.15% |
| 2016-03-31 | $1.00B | $0.14B | 13.96% |
| 2015-12-31 | $0.96B | $0.14B | 15.00% |
| 2015-06-30 | $0.53B | $0.10B | 18.57% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $4.095B | $2.743B |
| Surgery Partners, Inc. is a healthcare services company. The Company's outpatient delivery model focused on providing solutions for surgical and related ancillary care in support of its patients and physicians. Its operating segment consists of Surgical Facility Services segment, Ancillary Services segment and Optical Services segment. Surgery Partners, Inc. is based in Nashville, Tennessee. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $120.646B | 14.71 |
| Cencora (COR) | United States | $44.115B | 16.86 |
| ICON (ICLR) | Ireland | $23.604B | 21.21 |
| DiDi Global (DIDIY) | China | $22.358B | 0.00 |
| Avantor (AVTR) | United States | $17.717B | 26.87 |
| Revvity (RVTY) | United States | $15.582B | 27.29 |
| Natera (NTRA) | United States | $15.318B | 0.00 |
| Viatris (VTRS) | United States | $13.869B | 4.23 |
| CochLear (CHEOY) | Australia | $12.838B | 0.00 |
| Solventum (SOLV) | United States | $11.762B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.236B | 19.34 |
| Medpace Holdings (MEDP) | United States | $10.115B | 30.69 |
| Sonic Healthcare (SKHHY) | Australia | $9.094B | 0.00 |
| Doximity (DOCS) | United States | $7.896B | 50.03 |
| HealthEquity (HQY) | United States | $6.867B | 37.27 |
| Bausch + Lomb (BLCO) | Canada | $6.703B | 28.85 |
| PACS (PACS) | United States | $6.038B | 0.00 |
| Organon (OGN) | United States | $4.936B | 5.02 |
| Life Times (LTH) | United States | $4.869B | 40.70 |
| Sotera Health (SHC) | United States | $4.699B | 23.70 |
| Concentras Parent (CON) | United States | $2.871B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.727B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $2.542B | 95.71 |
| BrightSpring Health Services (BTSG) | United States | $2.524B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.127B | 0.00 |
| Premier (PINC) | United States | $1.989B | 8.94 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.961B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.620B | 8.14 |
| CareDx (CDNA) | United States | $1.572B | 0.00 |
| Agilon Health (AGL) | United States | $1.535B | 0.00 |
| Progyny (PGNY) | United States | $1.509B | 26.54 |
| Teladoc Health (TDOC) | United States | $1.440B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.151B | 0.00 | |
| QDM (QDMI) | Hong Kong, SAR China | $1.123B | 29.39 |
| GeneDx Holdings (WGS) | United States | $1.094B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.975B | 10.62 |
| Embecta (EMBC) | United States | $0.838B | 5.59 |
| InnovAge Holding (INNV) | United States | $0.774B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.543B | 0.00 |
| Sharecare (SHCR) | United States | $0.528B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.473B | 0.00 |
| Enhabit (EHAB) | United States | $0.399B | 34.48 |
| Sonida Senior Living (SNDA) | United States | $0.374B | 0.00 |
| DocGo (DCGO) | United States | $0.342B | 12.85 |
| Sera Prognostics (SERA) | United States | $0.247B | 0.00 |
| Biodesix (BDSX) | United States | $0.247B | 0.00 |
| LifeMD (LFMD) | United States | $0.224B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.188B | 0.00 |
| ModivCare (MODV) | United States | $0.173B | 5.48 |
| Beauty Health (SKIN) | United States | $0.170B | 0.00 |
| MultiPlan (MPLN) | United States | $0.127B | 0.00 |
| Nutex Health (NUTX) | United States | $0.094B | 0.00 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.088B | 0.00 |
| So-Young (SY) | China | $0.086B | 20.75 |
| SBC Medicals (SBC) | United States | $0.048B | 0.00 |
| NeueHealth (NEUE) | United States | $0.042B | 1.67 |
| OncoCyte (OCX) | United States | $0.040B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.039B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.037B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.033B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.028B | 0.00 |
| Oncology Institute (TOI) | United States | $0.023B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.017B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| KindlyMD (KDLY) | $0.007B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |